Li Wen-Rui, Zhang Chunping, Wang Jing
The Second Clinical Medical College, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
School of Basic Medical Sciences, Jiangxi Medical College, Nanchang University, Nanchang, 330006, Jiangxi, China.
Hormones (Athens). 2025 Mar;24(1):85-97. doi: 10.1007/s42000-024-00612-4. Epub 2024 Nov 6.
Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear hormone receptor family of ligand-activated receptors and are known for their roles as key factors in the regulation of lipid metabolism. In the more than three decades since their discovery, most reports on PPARs have focused on their roles in lipid metabolism, and a portion of the new research has also focused on the relationship between PPARs and fibrosis. Interestingly, lipid metabolism disorders and fibrosis are also inextricably linked. This implies that PPARs, lipid metabolism and fibrosis are interrelated. On this basis, we have summarized the molecular mechanisms of PPARs regulating fibrosis through lipid metabolism and PPARγ directly regulating fibrosis, and pointed out the contradictions and enigmas that need to be further explored in the processes of PPARs regulating lipid metabolism and fibrosis. The aim of the present review is to provide new ideas for PPARs for the treatment of lipid metabolism disorders and fibrosis.
过氧化物酶体增殖物激活受体(PPARs)属于配体激活受体的核激素受体家族,因其作为脂质代谢调节的关键因子而闻名。自发现以来的三十多年里,大多数关于PPARs的报道都集中在它们在脂质代谢中的作用,并且一部分新研究也聚焦于PPARs与纤维化之间的关系。有趣的是,脂质代谢紊乱与纤维化也有着千丝万缕的联系。这意味着PPARs、脂质代谢和纤维化是相互关联的。在此基础上,我们总结了PPARs通过脂质代谢调节纤维化以及PPARγ直接调节纤维化的分子机制,并指出了PPARs调节脂质代谢和纤维化过程中需要进一步探索的矛盾和谜团。本综述的目的是为PPARs治疗脂质代谢紊乱和纤维化提供新思路。